Design and baseline characteristics of the CagriSema cardiovascular outcomes trial (REDEFINE 3). Cavender MA, Jastreboff AM, Cheng AYY, Davies MJ, et al. Am Heart J 2026 Oct 6:107626. doi: 10.1016/j.ahj.2026.107626.

Read + Share

Amedeo Smart

Independent Medical Education

Cavender MA, Jastreboff AM, Cheng AYY, Davies MJ, et al. Design and baseline characteristics of the CagriSema cardiovascular outcomes trial (REDEFINE 3). Am Heart J 2026 Oct 6:107626. doi: 10.1016/j.ahj.2026.107626.
PMID: 42838477